FDA issues new warning on misuse of UCB cough drug

03/12/2008 | Yahoo!

The FDA on Tuesday released a new warning on the potentially lethal side effects of misusing Tussionex Pennkinetic Extended-Release Suspension, a cough treatment manufactured by UCB S.A. The agency received reports of health problems and deaths in children and adults who took the drug, which contains hydrocodone, a narcotic pain reliever. "The FDA's alert is fully in line with our efforts to make sure this product is properly used," a UCB spokewoman said.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health